Skip to main content
All lobbying filings

SMITHBUCKLIN CORPORATION

Lobbying for ASTCT · Healthcare Society

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $70,000.00 income · posted Jan 20, 2026

Official filing document

 Bills named in this filing 7
 Lobbying activity 3
Health Issues

Labor-HHS Appropriations Billing and Coding CAR-T Therapy Clarifications Revaccination of Immunosuppressed Patients Patient-Care Episode Financial Toxicity NIH Funding Cancer Moonshot H.R. 1509/S. 752, The Accelerating Kids Access to Care Act H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act

Medicare/Medicaid

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 1509/S. 752, the Accelerating Kids Access to Care Act - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act

Medical/Disease Research/Clinical Labs

- Labor-HHS Appropriations - CAR-T Therapy clarification - Cures 2.0 Engagement - Cancer Moonshot - NIH Funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem